More than 220 organizations, including the AHA, Friday urged Senate committee leaders to consider the Overdose Prevention and Patient Safety Act (H.R. 6082) and encourage Senate leadership to bring the bill to the floor for a vote during the lame-duck session. The House-passed bill would align federal regulations governing the confidentiality of drug and alcohol treatment and prevention records with the Health Insurance Portability and Accountability Act and strengthen consumer protections. 鈥淢odifying Part 2 to ensure that HIPAA-covered entities have access to a patient鈥檚 medical record will improve patient safety, treatment and outcomes across the care delivery spectrum, enhancing the entire opioid package passed by the House and Senate,鈥 the organizations said in a to leaders of the Senate Health, Education, Labor and Pensions Committee.

Related News Articles

Headline
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are鈥
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain鈥
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,鈥
Headline
The AHA released a new toolkit to improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for鈥
Headline
The Substance Abuse and Mental Health Services Administration July 28 released its latest national survey on drug use and mental health. Among the findings,鈥
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue鈥